Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.82M Sell
14,125
-1,154
-8% -$135K 0.19% 137
2026
Q1
$1.84M Buy
15,279
+437
+3% +$50.5K 0.23% 115
2025
Q4
$1.56M Buy
14,842
+353
+2% +$33.1K 0.19% 127
2025
Q3
$1.22M Buy
14,489
+5,827
+67% +$480K 0.16% 144
2025
Q2
$686K Buy
8,662
+580
+7% +$46.1K 0.12% 177
2025
Q1
$725K Sell
8,082
-2,334
-22% -$218K 0.15% 143
2024
Q4
$1.04M Buy
10,416
+2,600
+33% +$268K 0.2% 119
2024
Q3
$888K Buy
7,816
+4,077
+109% +$484K 0.2% 115
2024
Q2
$463K Buy
3,739
+540
+17% +$69.6K 0.14% 138
2024
Q1
$422K Buy
+3,199
New +$394K 0.16% 135

Other funds holding MRK

United Advisor Group's MRK Position: Q2 2026 in Review

United Advisor Group reduced its Merck (MRK) stake by 7.6% in Q2 2026, selling an estimated $135K and leaving 14,125 shares worth $1.82M. The position accounts for 0.19% of the portfolio, ranked #137.

United Advisor Group first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.84M in Q1 2026. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • United Advisor Group held 14,125 shares of Merck worth $1.82M as of Q2 2026.
  • United Advisor Group sold 1,154 Merck shares in Q2 2026, an estimated $135K.
  • Merck made up 0.19% of United Advisor Group's portfolio in Q2 2026, its #137 holding.
  • United Advisor Group first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • United Advisor Group's Merck position peaked at $1.84M in Q1 2026.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on United Advisor Group's 13F filing for Q2 2026, filed 29 Jul 2026.